NewcelX NCEL
NASDAQ NCEL
$2.84 +0.08 (+2.94%)
As of: Oct 21, 2026 · 9:58 AM EDT

NewcelX (NCEL) Non-Current Debt (2020 - 2022)

Updated

NewcelX's Non-Current Debt came in at -$111,730 for FY2021.

Analysis

NewcelX (NCEL) Non-Current Debt (2020 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,132.10 Bn 1,100.69 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 615.67 Bn 534.20 Bn 17.26 Bn 37.34 Bn
3 AbbVie 504.61 Bn 477.72 Bn 12.70 Bn 62.48 Bn
4 Merck 368.03 Bn 322.41 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.24 Bn 262.23 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.77 Bn 235.46 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.17 Bn 191.57 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.62 Bn 164.81 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 60.50 Bn
10 NewcelX 10.92 Mn 4.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 354,336.00
Dec 31, 2021 -277,537.00
Jun 30, 2021 -277,537.00
Dec 31, 2020 281,015.00
API Access

NewcelX Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=NCEL&period=max&api_key=YOUR_API_KEY